|
|
||||||||
The FASEB Journal, Vol 9, 115-119, Copyright © 1995 by The Federation of American Societies for Experimental Biology
RESEARCH COMMUNICATIONS |
J Lund, N Takahashi, JD Pound, M Goodall, H Nakagawa and R Jefferis
Department of Immunology, Medical School, Edgbaston, Birmingham, United Kingdom.
X-ray crystal structures of IgG-Fc provide evidence of extensive noncovalent interactions between the protein and carbohydrate moieties, and glycosylation, at Asn-297 within the Fc, has been shown to be important for effector functions mediated through Fc gamma receptors expressed on leukocytes. We have applied protein engineering in an attempt to define protein/carbohydrate interactions essential to wild- type biological activity. We demonstrate that replacement of Lys-246, Asp-249, and Glu-258, which make contacts with GlcNac and Gal on the outer alpha[1-->6] arm, do not affect recognition of human chimeric IgG3 by human Fc gamma RI and Fc gamma RII. However, replacement of Asp- 265, which make contacts with the primary GlcNac sugar residue and is covalently attached to Asn-297, resulted in loss of recognition of both Fc gamma RI and Fc gamma RII. Similarly, replacement of Asp-265 in mouse IgG2b resulted in loss of recognition by mouse Fc gamma RII. These results suggest that noncovalent contacts of Asp-265 with the primary GlcNac residue are important for maintenance of recognition of IgG by Fc gamma receptors whereas contacts with GlcNac and Gal on the alpha [1-->6] arm do not have a measurable effect. This conclusion was supported by experiments in which galactose-deficient and fully galactosylated forms of a human IgG4-Fc fragment were shown to be equivalent in their ability to inhibit superoxide generation by IgG4 stimulated U937 cells.
This article has been cited by other articles:
![]() |
M. Sack, A. Paetz, R. Kunert, M. Bomble, F. Hesse, G. Stiegler, R. Fischer, H. Katinger, E. Stoeger, and T. Rademacher Functional analysis of the broadly neutralizing human anti-HIV-1 antibody 2F5 produced in transgenic BY-2 suspension cultures FASEB J, June 1, 2007; 21(8): 1655 - 1664. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yasukawa, C. Sato, K. Sano, H. Ogawa, and K. Kitajima Identification of disialic acid-containing glycoproteins in mouse serum: a novel modification of immunoglobulin light chains, vitronectin, and plasminogen Glycobiology, July 1, 2006; 16(7): 651 - 665. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Jenmalm, H. Cherwinski, E. P. Bowman, J. H. Phillips, and J. D. Sedgwick Regulation of Myeloid Cell Function through the CD200 Receptor J. Immunol., January 1, 2006; 176(1): 191 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Collin and A. Olsen Extracellular Enzymes with Immunomodulating Activities: Variations on a Theme in Streptococcus pyogenes Infect. Immun., June 1, 2003; 71(6): 2983 - 2992. [Full Text] [PDF] |
||||
![]() |
M. El-Amine, J. A. Hinshaw, and D. W. Scott In vivo induction of tolerance by an Ig peptide is not affected by the deletion of FcR or a mutated IgG Fc fragment Int. Immunol., July 1, 2002; 14(7): 761 - 766. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kuroki, Y. Kuroda, S. Kikuchi, F. Lajaunias, T. Fulpius, Y. Pastore, L. Fossati-Jimack, L. Reininger, T. Toda, M. Nakata, et al. Level of galactosylation determines cryoglobulin activity of murine IgG3 monoclonal rheumatoid factor Blood, April 15, 2002; 99(8): 2922 - 2928. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Mimura, P. Sondermann, R. Ghirlando, J. Lund, S. P. Young, M. Goodall, and R. Jefferis Role of Oligosaccharide Residues of IgG1-Fc in Fcgamma RIIb Binding J. Biol. Chem., November 30, 2001; 276(49): 45539 - 45547. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wright and S. L. Morrison Effect of C2-Associated Carbohydrate Structure on Ig Effector Function: Studies with Chimeric Mouse-Human IgG1 Antibodies in Glycosylation Mutants of Chinese Hamster Ovary Cells J. Immunol., April 1, 1998; 160(7): 3393 - 3402. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Shields, A. K. Namenuk, K. Hong, Y. G. Meng, J. Rae, J. Briggs, D. Xie, J. Lai, A. Stadlen, B. Li, et al. High Resolution Mapping of the Binding Site on Human IgG1 for Fcgamma RI, Fcgamma RII, Fcgamma RIII, and FcRn and Design of IgG1 Variants with Improved Binding to the Fcgamma R J. Biol. Chem., February 23, 2001; 276(9): 6591 - 6604. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |